LEADER 01478nam  2200457   450 
001 9910155233203321
005 20180407081909.0
010   $a1-62257-100-2
035   $a(CKB)3710000000973774
035   $a(MiAaPQ)EBC4787181
035   $a(EXLCZ)993710000000973774
100   $a20170130h20122012  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aPharmaceutical innovation $echallenges and competitors /$fTomas E. Sanchez and Charles L. Scott, editors
210  1$aNew York, [New York] :$cNova Publishers,$d2012.
210  4$dİ2012
215   $a1 online resource (147 pages)
225 1 $aPharmacology - Research, Safety Testing and Regulation
300   $aIncludes index.
311   $a1-62257-068-5 
410  0$aPharmacology-research, safety testing, and regulation series.
606   $aPharmaceutical policy$zUnited States
606   $aPharmaceutical industry$zUnited States
606   $aDrug development$xTechnological innovations
615  0$aPharmaceutical policy
615  0$aPharmaceutical industry
615  0$aDrug development$xTechnological innovations.
676   $a362.17820973
702   $aSanchez$b Tomas E.
702   $aScott$b Charles L.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910155233203321
996   $aPharmaceutical innovation$92493629
997   $aUNINA